Cargando…
Liquid Biopsy Potential Biomarkers in Prostate Cancer
Prostate cancer (PCa) is the second most common cancer in men worldwide with an incidence of 14.8% and a mortality of 6.6%. Shortcomings in comprehensive medical check-ups in low- and middle-income countries lead to delayed detection of PCa and are causative of high numbers of advanced PCa cases at...
Autores principales: | Neuhaus, Jochen, Yang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316409/ https://www.ncbi.nlm.nih.gov/pubmed/30698162 http://dx.doi.org/10.3390/diagnostics8040068 |
Ejemplares similares
-
Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
por: GOZZETTI, ALESSANDRO, et al.
Publicado: (2023) -
Potential New Approaches for Prostate Cancer Management in Resource-Limited Countries in Africa
por: Bosland, Maarten C., et al.
Publicado: (2023) -
MicroRNAs as Potential Liquid Biopsy Biomarker for Patients with Castration-Resistant Prostate Cancer
por: Fernandez, Nicolas, et al.
Publicado: (2022) -
Molecular Dynamics Study of Laser Interaction with Nanoparticles in Liquids and Its Potential Application
por: Huang, Hao, et al.
Publicado: (2022) -
Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)